Rigetti Computing, Inc.

NASDAQ Capital Market
Slightly Bearish -20

Rigetti Computing (RGTI) Stock Tests Investor Nerve As Market Shock ...

πŸ“‰ RGTI stock trades near $15, down roughly 73% from its twelve-month high and significantly underperforming the S&P 500 which returned 17% over the same period.

πŸ’° Second-quarter 2026 revenue reached $5.1 million, driven by sales of on-premises Novera QPU hardware, up sharply from $1.8 million a year earlier.

🀝 The company finalized terms on a $100 million milestone-based CHIPS Act award agreement in early September to bolster its balance sheet.

πŸ’΅ Cash reserves stood at approximately $541 million at the end of June, representing roughly one-tenth of the company's market value near $5.1 billion.

πŸ“‰ Revenue from system access was minimal at just $143,000 in the first half of 2026, suggesting current sales are for research purposes rather than commercial deployment.

πŸ’Έ Operating expenses totaled $30.3 million in the second quarter, running at roughly six times revenue while cash fell about $28 million during the quarter.

🧠 Rigetti is one of three companies alongside IBM and Google to deliver a superconducting gate-based system with more than 100 qubits.

πŸ“‰ Historical data shows RGTI falling an average of 52% peak to trough during market shocks since 2022, compared with 13% for the S&P 500.

⏳ The company has recovered from all five historical market shocks with a median recovery time of roughly two months from the low back to the prior high.

Bullish Signals
  • Second-quarter 2026 revenue reached $5.1 million, up sharply from $1.8 million a year earlier, driven by sales of its on-premises Novera QPU hardware.
  • The company finalized terms on a $100 million milestone-based CHIPS Act award agreement in early September, adding meaningful external validation to its balance sheet story.
  • Cash stood at approximately $541 million at the end of June, providing a substantial liquidity buffer for its development roadmap.
  • Rigetti is one of only three companies alongside IBM and Google to deliver a superconducting gate-based system with more than 100 qubits.
Risk Factors
  • The stock trades roughly 73% below its twelve-month high, signaling that the price functions less as a valuation of current business and more as a bet on a future roadmap.
  • Revenue from access to its systems came in at just $143,000 in the first half of 2026, indicating customers are buying primarily for research purposes rather than commercial deployment.
  • Operating expenses of $30.3 million in the second quarter ran at roughly six times revenue, while cash fell about $28 million during the quarter with no debt on the books.
  • Management has been transparent that its systems are not close to quantum advantage, meaning current customers are buying them primarily for research purposes rather than commercial deployment.
  • Historical data shows RGTI falling an average of 52% peak to trough during market shocks since 2022, compared with 13% for the S&P 500 across the same events.
Full Analysis
Rigetti Computing (RGTI) shares are trading near $15, reflecting a significant divergence from the broader market as the stock has underperformed the S&P 500 despite recent operational progress. The company's valuation is currently driven by expectations of future quantum advantage rather than current business fundamentals, with investors pricing in a roadmap to reach that milestone within approximately three years. On the operational front, Rigetti reported second-quarter 2026 revenue of $5.1 million, a sharp increase from $1.8 million the prior year, primarily fueled by sales of its on-premises Novera QPU hardware. The company also secured a $100 million milestone-based award under the CHIPS Act in early September, providing external validation for its balance sheet which held approximately $541 million in cash as of June. However, analysts note that revenue from system access remains minimal at just $143,000 for the first half of 2026, indicating current customers are purchasing hardware primarily for research rather than commercial deployment. Operating expenses reached $30.3 million in the quarter, running at roughly six times revenue, while cash reserves decreased by about $28 million during the period without any debt on the books.